Xeris Biopharma Holdings, Inc. (XERS) — 10-Q Filings
All 10-Q filings from Xeris Biopharma Holdings, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Xeris Biopharma Revenue Soars, Narrows Losses in Q3
— Nov 6, 2025 Risk: medium
Xeris Biopharma Holdings, Inc. reported a significant increase in total revenue for the three and nine months ended September 30, 2025. Total revenue for the th -
Xeris Biopharma Q2 Revenue Jumps 24.8% on Strong Product Sales
— Aug 7, 2025 Risk: medium
Xeris Biopharma Holdings, Inc. reported product revenue of $40.5 million for the three months ended June 30, 2025, a significant increase from $32.1 million in -
Xeris Biopharma Files Q1 2025 10-Q
— May 8, 2025 Risk: medium
Xeris Biopharma Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates for the fir - 10-Q Filing — Aug 8, 2024
-
Xeris Biopharma Holdings Files Q1 2024 10-Q
— May 9, 2024 Risk: medium
Xeris Biopharma Holdings, Inc. filed its quarterly report for the period ended March 31, 2024. The company is incorporated in Delaware and its common stock trad
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX